Larimar Therapeutics Inc [LRMR] stock prices are up 3.66% to $6.52 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The LRMR shares have gain 3.00% over the last week, with a monthly amount drifted -16.09%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Larimar Therapeutics Inc [NASDAQ: LRMR] stock has seen the most recent analyst activity on October 03, 2024, when Wedbush initiated its Outperform rating and assigned the stock a price target of $22. Previously, H.C. Wainwright started tracking the stock with Buy rating on October 02, 2024, and set its price target to $15. On September 04, 2024, Robert W. Baird initiated with a Outperform rating and assigned a price target of $16 on the stock. Leerink Partners started tracking the stock assigning a Outperform rating and suggested a price target of $25 on April 03, 2024. Citigroup upgraded its rating to a Buy but $4.50 remained the price target by the analyst firm on November 17, 2023. Guggenheim started tracking with a Buy rating for this stock on October 19, 2022, and assigned it a price target of $12. In a note dated February 15, 2022, William Blair downgraded an Mkt Perform rating on this stock.
The stock price of Larimar Therapeutics Inc [LRMR] has been fluctuating between $2.18 and $13.68 over the past year. Currently, Wall Street analysts expect the stock to reach $17 within the next 12 months. Larimar Therapeutics Inc [NASDAQ: LRMR] shares were valued at $6.52 at the most recent close of the market. An investor can expect a potential return of 160.74% based on the average LRMR price forecast.
Analyzing the LRMR fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.38 and Total Capital is -0.3. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.09 points at the first support level, and at 5.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.16, and for the 2nd resistance point, it is at 7.79.
Ratios To Look Out For
It’s worth pointing out that Larimar Therapeutics Inc [NASDAQ:LRMR]’s Current Ratio is 10.93. In addition, the Quick Ratio stands at 10.93 and the Cash Ratio stands at 1.53.
Transactions by insiders
Recent insider trading involved Hamilton Thomas Edward, Director, that happened on Feb 16 ’24 when 57208.0 shares were purchased. Director, Flynn James E completed a deal on Feb 16 ’24 to buy 4.29 million shares. Meanwhile, Director THOMAS FRANK E bought 2000.0 shares on Feb 14 ’24.
